Mandate

Vinge has advised Main Capital in connection with its acquisition of Björn Lundén AB

Björn Lundén AB, founded in 1987, provides accounting and financial software solutions targeted at accounting firms and SMEs.

Björn Lundén serves over 30,000 companies in the Swedish market and has 120 employees. The company has developed a comprehensive portfolio of solutions and tools for administration, finance, accounting, tax, legal and personnel administration and in addition offers knowledge tools, books and courses in the aforementioned areas.

Vinge’s team consisted of Filip Öhrner, Henrik Borna, Daniel Daun, Lena Westberg, Ellinor Wargenbrant, Nando Basic, Jonathan Hörnblad (M&A), Emelie Svensäter Jerntorp, Karin Gynnerstedt (Employment), Lisa Bourghardt (IP) and Ellinore Boström Andersson.

Related

Vinge advises Aspo on its acquisition of Swed Handling

Vinge advises Aspo, listed on Nasdaq Helsinki, in the transaction whereby Aspo's subsidiary Telko expands its chemicals business in Sweden by acquiring Swed Handling, a leading Swedish chemical distributor, from TeRa Invest. As part of the transaction, Aspo’s subsidiary Leipurin expands its food industry business in Sweden, via the technical food ingredient distributor Kebelco, which is a subsidiary of Swed Handling. The closing of the transaction is subject to customary regulatory approvals.
April 30, 2024

Vinge advises on the sale of Vinnergi Holding AB

Vinge has advised Sobro and other shareholders in connection with the sale of Vinnergi Holding AB to Polaris, a Nordic investment firm. In connection with the transaction, the management and employees are reinvesting a significant portion to further develop the company. The Vinnergi Group conducts operations in technology consulting and software development in Sweden, with a particular focus on telecoms, energy and real estate.
April 30, 2024

Vinge has advised Pareto Securities in connection with a rights issue in Episurf Medical

Vinge has advised Pareto Securities in connection with a partially secured rights issue of units of up to approximately SEK 120 million in Episurf Medical.
April 24, 2024